Speaker illustration

Ms Emily Ghanbari

Berlin (Germany)

Protease-activated receptor 2 (PAR2) inhibition reduces complement-associated cardiac remodelling in obesity-related heart failure

Event: ESC Congress 2024

Topic: Ventricular Remodelling

Session: Obesity and heart failure: what's new?

Thumbnail